Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. SBI Mutual Fund buys Alkem Laboratories shares for Rs 300 crore

SBI Mutual Fund buys Alkem Laboratories shares for Rs 300 crore

24 Feb 2025

Add as preferred source
Key Takeaways

SBI Mutual Fund raised its stake to 2.7% via a ₹300.32 crore buy, despite a 2.54% stock dip.

SBI Mutual Fund raised its stake to 2.7% via a ₹300.32 crore buy, despite a 2.54% stock dip.

sbi fund management unlisted shares

SBI Fund Management

DRHP filed0.00%

Expert Analysis

SBI Mutual Fund Raises Alkem Stake with ₹300 Cr Buy.

Expert Analysis :

  • SBI MF Investment: SBI Mutual Fund bought additional Alkem Laboratories shares for ₹300 crore via an open market transaction on 21 Feb 2025.

  • Block Deal Details: SBI Mutual Fund acquired 6.41 lakh shares (0.54% stake) in Alkem Laboratories, as per NSE block deal data.

  • Stake & Price Details: SBI Mutual Fund bought shares at an average price of ₹4,680, raising its stake in Alkem from 2.16% to 2.7%, with a total transaction value of ₹300.32 crore.

  • Promoter Offloading: Samprada and Nanhamati Singh Family Trust (Alkem promoters) sold the same 6.41 lakh shares, as per NSE data.

  • Stock Decline: Alkem Laboratories’ stock fell 2.54%, closing at ₹4,600.05 on the NSE on Friday.

Publisher:msn.com